Platelet mass has prognostic value in patients with myelodysplastic syndromes

British Journal of Haematology

Volumn 135, Issue 2, 2006, Pages 198-200

  Bowles, Kristian M ^b   Warner, Brian A ^b   Baglin, Trevor P ^a,b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Myelodysplastic syndromes; Platelets; Prognostic factors; Thrombocytopenia

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CELL SIZE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PLATELET COUNT; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33748742144     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06246.x     Document Type: Article

References (9)

1. Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G. & Schneider, W. (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia, 6, 52-59.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
3. Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D. & Parker, J. (2003) Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. British Journal of Haematology, 120, 187-200.
4. Bowles, K.M., Cooke, L.J., Richards, E.M. & Baglin, T.P. (2005) Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clinical and Laboratory Haematology, 27, 370-373.
5. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
6. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 3835-3849.
7. Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F. & Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia, 7, 1315-1323.
8. Mufti, G.J., Stevens, J.R., Oscier, D.G., Hamblin, T.J. & Machin, D. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology, 59, 425-433.
9. Sanz, G.F., Sanz, M.A., Vallespi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395-408.